Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Journal of Cardiology
- Vol. 77 (3) , 292-299
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Applicability of a Risk Score for Prediction of the Long-Term (8-Year) Benefit of the Implantable Cardioverter-DefibrillatorJACC, 2012
- Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registryHeart, 2008
- High Prevalence of Renal Dysfunction and Its Impact on Outcome in 118,465 Patients Hospitalized With Acute Decompensated Heart Failure: A Report From the ADHERE DatabaseJournal of Cardiac Failure, 2007
- Accumulation of Risk Markers Predicts the Incidence of Sudden Death in Patients with Chronic Heart FailureEuropean Journal of Heart Failure, 2006
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Are the MADIT II Criteria for ICD Implantation Appropriate for Japanese Patients?Circulation Journal, 2005
- Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery DiseaseCirculation, 2002
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Congestive Heart Failure in the CommunityCirculation, 1998
- The Natural History of Congestive Heart Failure: The Framingham StudyNew England Journal of Medicine, 1971